For the year 2019, the overall cost of breast cancer treatment was EUR 4,259,045 in patients with HER2+ cancer, EUR 2,005,265 in those with luminal cancer, and EUR 143,413 in those with triple-negative tumors. The gene discussed is ERBB2; the disease is cancer.